Search results
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters via Yahoo News· 10 hours agoEli Lilly on Friday said its popular weight-loss drug Zepbound helped resolve moderate to severe...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the...
CNBC· 10 hours agoEli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the...
Eli Lilly seeks FDA’s OK to expand Zepbound’s uses to include sleep apnea
Market Watch· 10 hours agoEli Lilly & Co. said Friday that it has applied for U.S. regulatory approval to expand the use of...
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea
Associated Press via Yahoo News· 10 hours agoTirzepatide, the medication in the weight-loss drug Zepbound and also the diabetes treatment...
Eli Lilly Blasts Use of Mounjaro and Zepbound for “Cosmetic Weight Loss”
Futurism via Yahoo News· 9 hours agoThe pharmaceutical giant behind the popular weight loss injectables Zepbound and Mounjaro is,...
Zepbound: Weight Loss Drugs Can Help Reduce Sleep Apnea Symptoms
Healthline· 16 hours agoThe obesity and diabetes medication tirzepatide (Mounjaro, Zepbound) reduced obstructive sleep apnea...
Weight-Loss Drugs Dangers Explained: Zepbound, Mounjaro Maker Warn Of Coming Counterfeit Lawsuit
Forbes· 2 days agoSeveral medical spas and wellness centers are facing potential lawsuits from drugmaker Eli Lilly for...
Weight loss drug could help treat sleep apnea: Study
The Hill via AOL· 8 hours agoA popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound...
Eli Lilly is cracking down on knock-off versions of its popular weight loss drug Zepbound
Quartz· 2 days agoEli Lilly said Thursday that it is taking legal action against six entities for selling unapproved...
Eli Lilly Broadens Crackdown on Fake and Compounded Zepbound
Bloomberg· 2 days agoHave a confidential tip for our reporters? Eli Lilly & Co. broadened its effort to crack down on...